secwatch.observer — SEC 8-K summary
======================================

Issuer:     GLOBUS MEDICAL INC (GMED)
CIK:        0001237831
Form:       8-K
Filed at:   2023-09-01T23:59:59+00:00
Accession:  0001193125-23-227191
Event type: m_and_a
Sentiment:  positive
Materiality: 0.75
Item codes: 1.01, 2.01, 2.03, 3.02, 5.02, 7.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Globus Medical completes merger with NuVasive; expands board, converts notes
----------------------------------------------------------------------------

- NuVasive shareholders received 0.75 Globus shares per share; NuVasive stock ceased trading Aug 31.
- Globus Board expanded from 8 to 11; added NuVasive directors John DeFord, Leslie Norwalk, Daniel Wolterman.
- NuVasive's $450M 0.375% convertible notes now convertible into Globus common at 8.0399 shares/$1,000 principal.
- Globus guaranteed NuVasive's note obligations; also amended call/warrant options for Globus stock.
- Combined company positioned as leading global musculoskeletal firm; financial benefits to be discussed in Q3 call.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1237831/000119312523227191/0001193125-23-227191-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1237831/000119312523227191/d479094d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-227191

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer